The UK has established the National Institute for Health Research Medicines for Children Research Network to provide infrastructure to facilitate the conduct of randomized trials and other well designed studies sponsored by the pharmaceutical industry and public funding bodies. Clinical Studies Groups of experts establish priorities and assist in the development of protocols whilst Local Research Networks and an Extended Neonatal Network facilitate their implementation and conduct. Two Clinical Trials Units and a co-ordinating center assist in the development and conduct of studies and performance manage the network. Work streams on formulation and experimental medicine have been established. As of August 2008, 16 commercially sponsored studies had been adopted (from 12 different companies) and 65 publicly sponsored studies.